Fundz

Arrivobio Raises $45M In Series B Financing To Advance Pipeline

PRIVATENov 29, 2023

Amount Raised

$45 Million

Round Type

Series B

MorrisvilleBiotechnologyHealth CareTherapeutics

Investors

ArrivoRex Health VenturesSolas Bio Ventures Emerging Healthcare Fund, L.P.Orlando Health Ventures

Description

Arrivo BioVentures today announced the closing of an oversubscribed Series B preferred financing round, totaling $45.25 million in committed capital, bringing the total raised since the company’s inception to $100M.

Quick answer

ArrivoBio raised $45 Million in a Series B round, dated November 29, 2023. Investors: Arrivo, Rex Health Ventures, Solas Bio Ventures Emerging Healthcare Fund, L.P. and Orlando Health Ventures. ArrivoBio is based in Morrisville, New York, United States.

How much did ArrivoBio raise?
ArrivoBio raised $45 Million in a Series B round on November 29, 2023.
Who invested in ArrivoBio?
Arrivo, Rex Health Ventures, Solas Bio Ventures Emerging Healthcare Fund, L.P. and Orlando Health Ventures are named as investors in this round.
What does ArrivoBio do?
SP-624 is a small molecule that selectively activates the SIRT6 enzyme, a novel epigenetic mechanism known to modulate gene expression, metabolism and DNA repair.
Where is ArrivoBio based and how big is it?
ArrivoBio is based in Morrisville, New York, United States.
Who are the decision-makers at ArrivoBio?
Fundz holds 1 contact at ArrivoBio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as ArrivoBio that raised within 45 days of this round, from Fundz verified event records.

  • Gallant raised $15M (Series A) on January 8, 2024.
  • Lykos Therapeutics raised an undisclosed amount (Series A) on January 5, 2024.
  • Liquidia raised $100M (Funding Round) on January 4, 2024.
  • OnCusp Therapeutics raised $100M (Series A) on January 4, 2024.
  • Voyager Therapeutics raised $20M on January 3, 2024.
  • Alpha Cognition raised $1.8M (Seed) on December 22, 2023.

Who to call at ArrivoBio, and when

A new round usually means ArrivoBio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ArrivoBio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ArrivoBio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ArrivoBio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ArrivoBio

Location

Morrisville, New York, United States

About

SP-624 is a small molecule that selectively activates the SIRT6 enzyme, a novel epigenetic mechanism known to modulate gene expression, metabolism and DNA repair. Recent published literature suggests that human females and males exhibit gene expression changes in opposite directions when depressed.1 The results of Arrivo’s Phase 2 study with SP-624 appear to support this finding by demonstrating that female subjects on SP-624 experienced early and robust alleviation of depressive symptoms, unlike male patients in the study.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ArrivoBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for ArrivoBio's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

ArrivoBio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.